Consistent with the previous study [25], TAZ was not expressed in 22Rv1 and its sublines (data not shown), suggesting that nYAP1 expression and activation were associated with chemotherapy resistance in the 22Rv1 PCa cell line and that nYAP1 expression and activation have a potential to be associated with chemohormonal resistance for PCa. This evidence concerns the gene NYAP1 and posterior cortical atrophy.